Pfizer made an unsolicited bid to acquire AstraZeneca for approximately $118 billion, which would have been the largest pharmaceutical deal in history. AstraZeneca's board rejected the bid, and Pfizer ultimately withdrew after UK takeover rules prevented a further approach for six months.